Electrospun Silk Fibroin–Chlorin e6 Films for Photodynamic Antibacterial Therapy

Study Background and Research Question

Chronic wound infections, particularly those caused by multidrug-resistant Staphylococcus aureus (S. aureus), represent a persistent clinical challenge. The overuse and misuse of antibiotics have led to rising resistance, making conventional therapies increasingly ineffective. Biofilm formation by bacteria further impedes antibiotic penetration and fosters persistent infections. Given these hurdles, there is urgent interest in developing alternative antibacterial strategies that can disrupt biofilms and modulate inflammation without relying on traditional antibiotics. Photodynamic antibacterial therapy (PDAT), which utilizes photosensitizers to generate cytotoxic reactive oxygen species (ROS) under specific light activation, has emerged as a promising solution. However, limitations such as photosensitizer instability, rapid body clearance, and suboptimal biocompatibility have restricted its clinical translation. This study addresses whether integrating a second-generation photosensitizer, Chlorin e6 (Ce6), into a biocompatible silk fibroin scaffold can overcome these barriers and deliver effective, targeted antibacterial action for infected wound healing.

Key Innovation from the Reference Study

The central innovation reported by Li et al. (2024) is the fabrication of an aligned silk fibroin nanofiber film conjugated with Ce6 (SFCF@Film) via electrospinning. This design leverages both the structural and biological benefits of silk fibroin and the photodynamic properties of Ce6. The resulting composite not only provides a directional guidance cue for cell orientation and tissue regeneration but also enables spatially controlled ROS generation upon near-infrared (NIR) irradiation, achieving rapid and efficient bacterial killing directly at the wound site. Notably, the SFCF@Film also modulates macrophage polarization toward a pro-regenerative M2 phenotype, offering dual action in infection control and tissue repair.

Methods and Experimental Design Insights

The study employed a multi-step fabrication and characterization approach:

• Silk fibroin extraction and preparation: Silk fibroin was isolated from silkworm cocoons, purified, and processed into an aqueous solution suitable for electrospinning.
• Electrospinning of Ce6-functionalized fibers: Ce6 was covalently conjugated to silk fibroin, and the mixture was electrospun onto a silk fibroin film substrate to generate aligned nanofiber arrays (SFCF@Film).
• Mechanical and biocompatibility testing: The composite film was assessed for tensile strength, hemocompatibility, and cytocompatibility with mammalian cells, ensuring suitability as a wound dressing.
• In vitro and in vivo antibacterial efficacy: The photodynamic antibacterial performance was evaluated by exposing SFCF@Film to NIR irradiation in the presence of S. aureus cultures and infected wound models, quantifying ROS generation, bacterial viability, and histological wound healing outcomes.
• Macrophage polarization analysis: Immunohistochemical and flow cytometry assays were used to investigate the effect of the scaffold on macrophage phenotype, distinguishing between pro-inflammatory (M1) and pro-regenerative (M2) populations during healing.

Protocol Parameters

• Ce6 conjugation to silk fibroin: Covalent binding of Ce6 to silk fibroin, with concentrations optimized for maximal ROS generation and minimal cytotoxicity to host cells.
• Electrospinning conditions: Parameters adjusted to produce aligned nanofibers, enhancing directional cell growth; typical voltage, flow rate, and collection distance based on standard silk fibroin electrospinning protocols.
• NIR irradiation: Application of near-infrared light (wavelength matching Ce6 absorption) for 10 minutes, sufficient to activate ROS-mediated antibacterial effects in vitro and in vivo.
• Wound infection model: S. aureus-infected murine wounds treated with SFCF@Film and monitored for bacterial reduction and tissue regeneration over time.

Core Findings and Why They Matter

The aligned SFCF@Film demonstrated several key outcomes:

• Enhanced photodynamic antibacterial activity: Upon NIR irradiation, the film generated high levels of ROS, rapidly eradicating S. aureus within 10 minutes and disrupting biofilm structures (see study).
• Promotion of wound healing: SFCF@Film provided structural and biochemical cues that directed cell growth and accelerated tissue repair in infected wounds.
• Immunomodulation: The scaffold promoted M2 macrophage polarization, reducing chronic inflammation and supporting tissue regeneration.
• Mechanical and hemocompatibility properties: The composite maintained robust tensile strength and exhibited low hemolysis, making it suitable for clinical wound dressing applications.

These findings underscore the potential of biomaterial-based delivery systems to enhance the therapeutic index of photosensitizers like Ce6, addressing both infection and wound healing simultaneously. The study also demonstrates that combining physical scaffold alignment with photodynamic action can synergistically improve tissue repair outcomes.

Comparison with Existing Internal Articles

The role of Ce6 as a photosensitizer in both cancer and antibacterial photodynamic therapy has been reviewed in "Chlorin e6 Photosensitizer in Anticancer and Antibacterial PDT", where its broad cytotoxic capabilities upon light activation are discussed. The present study builds on these concepts by embedding Ce6 into a tissue engineering scaffold, thus overcoming the limitations of free photosensitizer agents, such as rapid clearance and poor localization. Further mechanistic insights into ROS generation and clinical translation of Ce6 are explored in "Chlorin e6 (Ce6): Mechanistic Insights and Clinical Potential in Photodynamic Therapy", supporting the rationale for incorporating Ce6 into advanced biomaterials for infection management. Compared to these reviews, the current study provides direct experimental evidence for the efficacy of a Ce6-conjugated silk fibroin scaffold in a challenging wound infection model, demonstrating practical advances over previous in vitro or theoretical discussions.

Limitations and Transferability

While the aligned SFCF@Film system shows strong preclinical promise, several limitations are noted:

• Model specificity: The findings are based on S. aureus-infected murine models; efficacy against other pathogens or in different tissue environments remains to be validated.
• Scalability and regulatory translation: The fabrication process, while robust in the laboratory, may require optimization for large-scale, reproducible clinical production.
• Long-term biocompatibility: Although short-term hemocompatibility and cytocompatibility are demonstrated, extended in vivo studies are necessary to assess chronic immune responses and scaffold degradation.

Transferability to other wound types or patient populations should be approached cautiously, with further research needed to confirm performance in diverse clinical scenarios.

Research Support Resources

For researchers interested in developing similar photodynamic antibacterial therapies or biomaterial–photosensitizer composites, high-purity Chlorin e6 (Ce6) (SKU B8314) is available for experimental use. Ce6 is a widely studied photosensitizer with demonstrated efficacy in both anticancer and antibacterial photodynamic protocols, supporting workflows that require robust ROS generation and cellular apoptosis induction. For further background on Ce6’s properties, solubility, and practical handling, consult the supplier's technical resources. As shown in this study, conjugation of Ce6 within electrospun biopolymer scaffolds is a promising research direction for addressing antibiotic-resistant infections and promoting wound healing. Researchers can adapt these protocols using commercially available Ce6 to optimize their own experimental platforms.